Literature DB >> 16055958

Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy.

E Bonnet1, C Delpierre, A Sommet, F Marion-Latard, R Hervé, C Aquilina, E Labau, M Obadia, B Marchou, P Massip, B Perret, J Bernard.   

Abstract

The aim of this study was to define standard values for fat mass distribution by dual-energy X-ray absorptiometry in human immunodeficiency virus (HIV)-negative men and to analyze factors associated with lipodystrophy in HIV-infected men. Total-body composition was analyzed in 241 HIV-negative men (controls) and 162 HIV-infected men. We created a fat mass ratio (FMR) as the ratio of the percentage of the trunk fat mass to the percentage of the lower limbs fat mass. We defined the FMR standard values as the mean value+/-standard deviation. We compared body mass index (BMI), fat mass percentage (%FM), lean mass (LM), bone mineral density (BMD), and FMR between the control group and HIV-infected men, by age range, according to prescription of treatment and presence of clinical lipodystrophy. The FMR standard value is equal to 1.3+/-0.2. The FMR was higher in treated HIV-infected men with or without clinical lipodystrophy. The FMR was similar for naïve HIV-infected men and controls. It was positively correlated with age, cumulative time on treatment, zidovudine, stavudine, or indinavir. BMD and fat mass were lower for treated and naïve HIV-infected men than for HIV-negative men. The FMR seems to be a valuable index for measuring fat mass distribution. We defined FMR standard values from the largest group of HIV-negative men to our knowledge. Applying FMR to HIV patients could help physicians to diagnose lipodystrophy earlier.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16055958     DOI: 10.1385/jcd:8:3:287

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.963


  27 in total

1.  IL-4 and IL-6 levels and adipose tissue distribution in HIV-1 patients under antiretroviral therapy.

Authors:  S Belo; A C Santos; A Madureira; J Pereira; A Sarmento; D Carvalho; P Freitas
Journal:  J Endocrinol Invest       Date:  2015-02-27       Impact factor: 4.256

Review 2.  Adipose Tissue in HIV Infection.

Authors:  John R Koethe
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

3.  Prevalence of obesity and its relationship to clinical lipodystrophy in HIV-infected adults on anti-retroviral therapy.

Authors:  P Freitas; D Carvalho; A C Santos; M J Matos; A J Madureira; R Marques; E Martinez; A Sarmento; J L Medina
Journal:  J Endocrinol Invest       Date:  2011-12-16       Impact factor: 4.256

4.  Hepatic steatosis associated with increased central body fat by dual-energy X-ray absorptiometry and uncontrolled HIV in HIV/hepatitis C co-infected persons.

Authors:  Todd T Brown; Shruti H Mehta; Catherine Sutcliffe; Yvonne Higgins; Michael S Torbenson; Richard D Moore; David L Thomas; Mark S Sulkowski
Journal:  AIDS       Date:  2010-03-27       Impact factor: 4.177

5.  Hip bone geometry in HIV/HCV-co-infected men and healthy controls.

Authors:  V Walker Harris; C G Sutcliffe; A B Araujo; G R Chiu; T G Travison; S Mehta; M S Sulkowski; Y Higgins; D L Thomas; A S Dobs; T J Beck; T T Brown
Journal:  Osteoporos Int       Date:  2011-09-08       Impact factor: 4.507

6.  A study on strategies for improving growth and body composition after renal transplantation.

Authors:  Jorge R Ferraris; Titania Pasqualini; Guillermo Alonso; Susana Legal; Patricia Sorroche; Ana Galich; Paula Coccia; Lidia Ghezzi; Verónica Ferraris; Liliana Karabatas; Clara Guida; Héctor Jasper
Journal:  Pediatr Nephrol       Date:  2010-02-12       Impact factor: 3.714

7.  Proposed ratios and cutoffs for the assessment of lipodystrophy in HIV-seropositive individuals.

Authors:  R A Beraldo; H S Vassimon; D C Aragon; A M Navarro; F J Albuquerque de Paula; M C Foss-Freitas
Journal:  Eur J Clin Nutr       Date:  2014-07-30       Impact factor: 4.016

8.  Dual energy X-Ray absorptiometry body composition reference values from NHANES.

Authors:  Thomas L Kelly; Kevin E Wilson; Steven B Heymsfield
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

9.  Central/Peripheral fat mass ratio is associated with increased risk of hypertension in HIV-infected patients.

Authors:  Paula Freitas; Davide Carvalho; Ana Cristina Santos; António José Madureira; Sandra Xerinda; Esteban Martinez; Jorge Pereira; António Sarmento; José Luís Medina
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-06-13       Impact factor: 3.738

10.  Lipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance.

Authors:  Paula Freitas; Davide Carvalho; Ana Cristina Santos; Joana Mesquita; Maria João Matos; Antonio Jose Madureira; Esteban Martinez; António Sarmento; José Luís Medina
Journal:  BMC Infect Dis       Date:  2012-08-06       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.